BPS Live: Precision Prevention - UKPGx Network





 

“Prevention is better than cure”

This well-known phrase, attributed to Erasmus in the 1500s, rings as true today as it did centuries ago. But how can we use modern approaches to meet the needs of different people?


Population-based prevention methods have been successful in some but not all areas, and there is an argument that we need precision prevention strategies to tackle some of the major issues facing healthcare in the 21st century. Indeed, the UK Government has identified prevention as important part of its strategy for the NHS.

Precision prevention uses biologic, pharmaceutical, digital, behavioural, socioeconomic and epidemiologic data and interventions to create strategies for reducing disease and mortality in specific individuals or groups of individuals.*

In this discussion, we will address some of the issues around precision prevention from the perspectives of different stakeholders, with the aim of publishing a position paper in this area. This session is online and free to attend, and we hope this will be of interest to individuals from healthcare, academia, industry and regulators, as well as members of the public.




*
(modified from Rebbeck, Cancer Epidemiol Biomarkers. 2014;23(12):2713–15).
 

Time Speaker Title
1000-1010 Munir Pirmohamed Introduction
1010-1035 Harry Hemingway Using data for precision prevention
1035-1100 Sarah Blagden Precision prevention in cancer
1100-1125 Steve Gardiner Precision prevention in chronic diseases – an industry perspective
1125-1150 Dan O’Connor How regulation can help to unlock the potential of preventative medicines
1150-1215 Shirley Hopper Precision prevention: a regulatory perspective
1215-1300 Lunch break
1300-1400 Breakout groups

Breakout group 1:
Do we need precision prevention or just better application of generalised public health prevention strategies?
Chair and rapporteur TBC

Breakout group 2:
How can the NHS, industry and regulators work together to deliver precision prevention approaches?
Chair and rapporteur TBC

Breakout group 3:
Can pharmacogenomics be regarded as a technology for precision prevention?
Chair and rapporteur TBC
1400-1415 Break
1415-1445 Munir Pirmohamed Feedback from breakout groups
1445-1500 Munir Pirmohamed Close and next steps

Tickets


Online Ticket Non-Member Ticket Free
From
05 March 2025
To
05 March 2025



Connect with us:

© 2025 British Pharmacological Society, The Schild Plot, 16 Angel Gate, City Road, London EC1V 2PT, United Kingdom

loading